ERBB2 and breast carcinoma: There are four subtypes that correlate with prognosis and define treatment strategies: luminal A, luminal B, HER2-enriched, and triple-negative breast cancer.95 At the transcriptional level, Her2+, luminal A, and luminal B subtypes also exist in malignant epithelial cells of breast cancer.